banner
HIV protease inhibitor Darunavir ethanolate, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ951

HIV protease inhibitor Darunavir ethanolate, Purity ≥98%

Synonym: 635728-49-3; HIV protease inhibitor; Prezista; TMC114

  • MDL: MFCD18251642
  • CAS Number: 635728-49-3
  • Compound CID: 23725083
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Darunavir ethanolate, soluble in DMSO and insoluble in ethanol and water, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV protease.
Molecular Weight
593.74
Molecular Formula
C27H37N3O7S.C2H6O
Targets
HIV protease
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 91 mg/mL (153.26 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Darunavir ethanolate is an HIV protease inhibitor developed to treat resistant strains of HIV by blocking proteolytic activity necessary for viral maturation.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0